COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

Trump signs order to use AI to accelerate pediatric cancer research

President Trump has signed an executive order to use artificial intelligence to accelerate research in pediatric cancers.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

In Brief

UC Davis Health and UCLA co-lead $16M study of AI use in breast cancer diagnosis

UC Davis Health and UCLA are co-leading a newly funded national clinical trial to evaluate whether AI can help radiologists interpret screening mammograms more accurately. The goal is to improve breast cancer detection and reduce unnecessary callbacks and anxiety for patients.

September 26, 2025

Vol.51 No.35

Clinical Roundup

Tecvayli + Darzalex Faspro achieves 100% MRD negativity in newly diagnosed MM, phase II study shows

An investigational immune-based induction regimen with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) demonstrated meaningful clinical efficacy in transplant-eligible patients with newly diagnosed multiple myeloma.

September 26, 2025

Vol.51 No.35

In Brief

City of Hope expands clinical trial access across U.S. with new national model

City of Hope launched a national clinical trials model to expand access to emerging life-saving cancer treatments to more patients across the country.

September 19, 2025

Vol.51 No.34

In Brief

Casey Graves appointed general manager of clinical solutions at ConcertAI

ConcertAI named Casey Graves general manager of Clinical Solutions. In this role, Graves will drive growth and innovation in real-world data and AI solutions for oncology research and clinical care, accelerating advances that improve outcomes for patients and healthcare providers.

September 19, 2025

Vol.51 No.34